Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
AbbVie (NYSE:ABBV) Shares Down 2.5% - Here's What Happened
What Are Wall Street Analysts' Target Price for AbbVie Stock?
AbbVie Earnings: Maintaining Our Fair Value Estimate Following a Steady Second Quarter | Morningstar
AbbVie (NYSE:ABBV) Given New $285.00 Price Target at Cantor Fitzgerald - Markets Daily
AbbVie (NYSE:ABBV) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says
3 Top Dividend Stocks to Buy Before Their Next Payout
Sapient Capital LLC Has $44.56 Million Stake in AbbVie Inc. $ABBV
Best Pharmaceutical Stocks To Follow Today - August 2nd - Markets Daily
ABBV Stock: Q2 Dip Is a Buying Opportunity With $300 Ahead
AbbVie Quietly Solved Its Biggest Problem-Now What?
Best Biotech Stocks To Add to Your Watchlist - August 2nd - Stock Observer
Flagship Wealth Advisors LLC Reduces Stock Holdings in AbbVie Inc. $ABBV
First Nebraska Trust Co Buys Shares of 7,118 AbbVie Inc. $ABBV
Financial Solutions Advisory Group Inc. Purchases New Stake in AbbVie Inc. $ABBV - Markets Daily
9,761 Shares in AbbVie Inc. $ABBV Purchased by Financial Solutions Advisory Group Inc.
AbbVie (NYSE:ABBV) Shares Down 2.4% - What's Next? - Daily Political
AbbVie Adjusts 2026 Profit Outlook After $10.9 Billion Apogee Buy, Reports Strong Q2 Results, ETPharma
Best Pharmaceutical Stocks To Keep An Eye On - July 29th - Markets Daily
4,955 Shares in AbbVie Inc. $ABBV Purchased by Montchanin Asset Management LLC
Segall Bryant & Hamill LLC Takes $43.63 Million Position in AbbVie Inc. $ABBV - Stock Observer
AbbVie (NYSE:ABBV) Posts Earnings Results, Beats Estimates By $0.04 EPS - Daily Political
AbbVie Inc. $ABBV Shares Acquired by Capasso Planning Partners LLC - Daily Political
Glenmede Trust Co. NA Has $74.19 Million Stake in AbbVie Inc. $ABBV - Daily Political
Why AbbVie Stock Slumped Today
AbbVie (NYSE:ABBV) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS - Zolmax
AbbVie (NYSE:ABBV) Announces Earnings Results, Beats Estimates By $0.05 EPS - Zolmax
AbbVie's Skyrizi and Rinvoq Launches Support Lengthy Patent Protection and a Wide Moat | Morningstar
AbbVie (NYSE:ABBV) Releases Earnings Results, Beats Estimates By $0.05 EPS
AbbVie (NYSE:ABBV) Stock Price Down 2.4% - Time to Sell? - Zolmax
Health Care Down on Rotation Out of Defense - Health Care Roundup | Morningstar
AbbVie (NYSE:ABBV) Trading Down 2.4% - Should You Sell?
AbbVie Inc (ABBV) (Q2 2026) Earnings Call Highlights: Robust Growth Driven by Skyrizi and ...
XLV vs. IHE: Which Healthcare ETF Is the Better Buy?
Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or Invesco's Equal-Weight RSPH?
AbbVie Q2 Earnings Call Highlights
AbbVie Beats but Cuts Guidance on $10.9 Billion Acquisition
Best Medical Stocks To Follow Now - July 31st - Stock Observer
AbbVie Lowers Outlook to Account for Acquisition, as 2Q Profit Jumps | Morningstar
AbbVie shares fall on earnings miss and weak guidance
AbbVie Trims FY26 Adj. EPS Outlook - Update
AbbVie Profit Rises In Q2
AbbVie trims 2026 profit forecast on Apogee buy, beats second-quarter estimates
AbbVie (NYSE:ABBV) Issues Q3 2026 Earnings Guidance - Stock Observer
Pharmaceutical Stocks To Add to Your Watchlist - July 31st - Daily Political
AbbVie Q2 26 Earnings Conference Call At 9:00 AM ET
AbbVie Inc. $ABBV Shares Sold by Vestor Capital LLC
AbbVie Inc. $ABBV Shares Purchased by Groupe la Francaise
FinArc Investments Inc. Makes New Investment in AbbVie Inc. $ABBV
Western Wealth Management LLC Grows Stock Position in AbbVie Inc. $ABBV - Stock Observer
FinArc Investments Inc. Takes $1.15 Million Position in AbbVie Inc. $ABBV - Stock Observer
AbbVie News | Markets Insider
Friday's big stock stories: What's likely to move the market in the next trading session
AbbVie (NYSE:ABBV) Stock Price Down 2.2% - Here's Why
Best Pharmaceutical Stocks To Research - July 30th - Stock Observer
AbbVie Inc. $ABBV Shares Acquired by Hamilton Wealth LLC
Bank of America Corp DE Reduces Stock Position in AbbVie Inc. $ABBV - Markets Daily
Bank of America Corp DE Trims Position in AbbVie Inc. $ABBV - Stock Observer
Pharmaceutical Stocks To Watch Today - July 27th - Daily Political
Breast implant associated anaplastic large cell lymphoma is a heterogeneous T cell disease with active pro-tumour cross-talk and immune suppression
Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Now
Investors Buy Large Volume of AbbVie Call Options (NYSE:ABBV)
AbbVie (ABBV) Stock: Rises as RINVOQ Wins EU Approval for Severe Hair Loss
AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now?
AbbVie Gets Europe OK for Rinvoq in Vitiligo, Alopecia Areata | Morningstar
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo | Morningstar
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata | Morningstar
AbbVie Secures EU Approval for Rinvoq to Treat Severe Alopecia Areata
AbbVie Wins EC Approval For Rinvoq In Non-Segmental Vitiligo
AbbVie Inc. $ABBV Shares Bought by Opal Capital LLC
AbbVie (ABBV) Expected to Announce Quarterly Earnings on Friday - Zolmax
Encore Global Management LP Takes $544,000 Position in AbbVie Inc. $ABBV
AbbVie (ABBV) Stock May Be Mispriced On Its 172% Run
AbbVie Secures EC Nod For RINVOQ In Severe Alopecia Areata
Amundi Has $2.33 Billion Holdings in AbbVie Inc. $ABBV
Pharmaceutical Stocks To Add to Your Watchlist - July 28th - Stock Observer
AbbVie Inc. $ABBV Shares Acquired by Lazard Asset Management LLC - Stock Observer
Encore Global Management LP Invests $544,000 in AbbVie Inc. $ABBV - Stock Observer
California State Teachers Retirement System Sells 62,377 Shares of AbbVie Inc. $ABBV - Stock Observer
AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer
Goldman Sachs uncovers key AbbVie stock signals before earnings
De-escalation trials in multiple myeloma: past, present and future
AbbVie (NYSE:ABBV) Trading 2.6% Higher - What's Next?
3 Major Reasons for Investors to Buy AbbVie Stock Before July 31st
Pharmaceutical Stocks To Add to Your Watchlist - July 28th - Daily Political
Empowered Funds LLC Acquires 78,374 Shares of AbbVie Inc. $ABBV - Daily Political
AbbVie (ABBV) Launches Boey In Europe With A Different Take On Wrinkle Injectables
Johnson & Johnson (NYSE:JNJ) Trading 1.1% Higher - Should You Buy? - Markets Daily
The Engine Behind ABBV Stock Has Real Parts
Latest news
Show more
Gold Price Today, August 4: Gold Edges Higher Near $4,060 Ahead of US Labor Data
NVIDIA Stock Rises 2.9% as AI Infrastructure and Quantum Shares Rally
Palantir Stock Surges as U.S. Commercial Revenue Jumps 149% and 2026 Guidance Rises
